Literature DB >> 20379150

Altered intramuscular lipid metabolism relates to diminished insulin action in men, but not women, in progression to diabetes.

Leigh Perreault1, Bryan C Bergman, Devon M Hunerdosse, Robert H Eckel.   

Abstract

Whether sex differences in intramuscular triglyceride (IMTG) metabolism underlie sex differences in the progression to diabetes are unknown. Therefore, the current study examined IMTG concentration and fractional synthesis rate (FSR) in obese men and women with normal glucose tolerance (NGT) vs. those with prediabetes (PD). PD (n = 13 men and 7 women) and NGT (n = 7 men and 12 women) groups were matched for age and anthropometry. Insulin action was quantified using a hyperinsulinemic-euglycemic clamp with infusion of [6,6-(2)H(2)]-glucose. IMTG concentration was measured by gas chromatography/mass spectrometry (GC/MS) and FSR by GC/combustion isotope ratio MS (C-IRMS), from muscle biopsies taken after infusion of [U-(13)C]palmitate during 4 h of rest. In PD men, the metabolic clearance rate (MCR) of glucose was lower during the clamp (4.71 ± 0.77 vs. 8.62 ± 1.26 ml/kg fat-free mass (FFM)/min, P = 0.04; with a trend for lower glucose rate of disappearance (Rd), P = 0.07), in addition to higher IMTG concentration (41.2 ± 5.0 vs. 21.2 ± 3.4 µg/mg dry weight, P ≤ 0.01), lower FSR (0.21 ± 0.03 vs. 0.42 ± 0.06 %/h, P ≤ 0.01), and lower oxidative capacity (P = 0.03) compared to NGT men. In contrast, no difference in Rd, IMTG concentration, or FSR was seen in PD vs. NGT women. Surprisingly, glucose Rd during the clamp was not different between NGT men and women (P = 0.25) despite IMTG concentration being higher (42.6 ± 6.1 vs. 21.2 ± 3.4 µg/mg dry weight, P = 0.03) and FSR being lower (0.23 ± 0.04 vs. 0.42 ± 0.06 %/h, P = 0.02) in women. Alterations in IMTG metabolism relate to diminished insulin action in men, but not women, in the progression toward diabetes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20379150      PMCID: PMC3230250          DOI: 10.1038/oby.2010.76

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  39 in total

Review 1.  Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity.

Authors:  Cédric Moro; Sudip Bajpeyi; Steven R Smith
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-11-14       Impact factor: 4.310

2.  New methods for calculating metabolic rate with special reference to protein metabolism.

Authors:  J B DE B WEIR
Journal:  J Physiol       Date:  1949-08       Impact factor: 5.182

3.  Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes.

Authors:  Renate E van Genugten; Kristina M Utzschneider; Jenny Tong; Fernando Gerchman; Sakeneh Zraika; Jayalakshmi Udayasankar; Edward J Boyko; Wilfred Y Fujimoto; Steven E Kahn
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

Review 4.  Muscular diacylglycerol metabolism and insulin resistance.

Authors:  Silvie Timmers; Patrick Schrauwen; Johan de Vogel
Journal:  Physiol Behav       Date:  2007-12-14

5.  Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program.

Authors:  Leigh Perreault; Yong Ma; Sam Dagogo-Jack; Edward Horton; David Marrero; Jill Crandall; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2008-03-20       Impact factor: 19.112

6.  Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance.

Authors:  Li Liu; Yiying Zhang; Nancy Chen; Xiaojing Shi; Bonny Tsang; Yi-Hao Yu
Journal:  J Clin Invest       Date:  2007-05-17       Impact factor: 14.808

7.  Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance.

Authors:  Simon Schenk; Jeffrey F Horowitz
Journal:  J Clin Invest       Date:  2007-05-17       Impact factor: 14.808

8.  Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content.

Authors:  Frederico G S Toledo; Elizabeth V Menshikova; Koichiro Azuma; Zofia Radiková; Carol A Kelley; Vladimir B Ritov; David E Kelley
Journal:  Diabetes       Date:  2008-02-05       Impact factor: 9.461

9.  Inflexibility in intramuscular triglyceride fractional synthesis distinguishes prediabetes from obesity in humans.

Authors:  Leigh Perreault; Bryan C Bergman; Devon M Hunerdosse; Mary C Playdon; Robert H Eckel
Journal:  Obesity (Silver Spring)       Date:  2009-12-24       Impact factor: 5.002

10.  Intramuscular lipid metabolism in the insulin resistance of smoking.

Authors:  Bryan C Bergman; Leigh Perreault; Devon M Hunerdosse; Mary C Koehler; Ali M Samek; Robert H Eckel
Journal:  Diabetes       Date:  2009-07-06       Impact factor: 9.461

View more
  24 in total

1.  Measurement of precursor enrichment for calculating intramuscular triglyceride fractional synthetic rate.

Authors:  Xiao-Jun Zhang; Noe A Rodriguez; Lijian Wang; Demidmaa Tuvdendorj; Zhanpin Wu; Alai Tan; David N Herndon; Robert R Wolfe
Journal:  J Lipid Res       Date:  2011-09-20       Impact factor: 5.922

Review 2.  Different physiological mechanisms underlie an adverse cardiovascular disease risk profile in men and women.

Authors:  Alan Fappi; Bettina Mittendorfer
Journal:  Proc Nutr Soc       Date:  2019-07-25       Impact factor: 6.297

3.  Acute hyperinsulinemia and reduced plasma free fatty acid levels decrease intramuscular triglyceride synthesis.

Authors:  Xiao-jun Zhang; Lijian Wang; Demidmaa Tuvdendorj; Zhanpin Wu; Noe A Rodriguez; David N Herndon; Robert R Wolfe
Journal:  Metabolism       Date:  2012-08-13       Impact factor: 8.694

4.  DGKζ deficiency protects against peripheral insulin resistance and improves energy metabolism.

Authors:  Boubacar Benziane; Melissa L Borg; Robby Z Tom; Isabelle Riedl; Julie Massart; Marie Björnholm; Marc Gilbert; Alexander V Chibalin; Juleen R Zierath
Journal:  J Lipid Res       Date:  2017-10-24       Impact factor: 5.922

5.  Fenofibrate administration does not affect muscle triglyceride concentration or insulin sensitivity in humans.

Authors:  Leigh Perreault; Bryan C Bergman; Devon M Hunerdosse; David J Howard; Robert H Eckel
Journal:  Metabolism       Date:  2011-02-08       Impact factor: 8.694

Review 6.  Defect of insulin signal in peripheral tissues: Important role of ceramide.

Authors:  Rima Hage Hassan; Olivier Bourron; Eric Hajduch
Journal:  World J Diabetes       Date:  2014-06-15

7.  Intramuscular triglyceride synthesis: importance in muscle lipid partitioning in humans.

Authors:  Bryan C Bergman; Leigh Perreault; Allison Strauss; Samantha Bacon; Anna Kerege; Kathleen Harrison; Joseph T Brozinick; Devon M Hunerdosse; Mary C Playdon; William Holmes; Hai Hoang Bui; Phil Sanders; Parker Siddall; Tao Wei; Melissa K Thomas; Ming Shang Kuo; Robert H Eckel
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-10-03       Impact factor: 4.310

8.  Lipid signals and insulin resistance.

Authors:  Chongben Zhang; Eric L Klett; Rosalind A Coleman
Journal:  Clin Lipidol       Date:  2013-12

9.  Sex Differences in Insulin Sensitivity are Related to Muscle Tissue Acylcarnitine But Not Subcellular Lipid Distribution.

Authors:  Josiane L Broussard; Leigh Perreault; Emily Macias; Sean A Newsom; Kathleen Harrison; Hai Hoang Bui; Paul Milligan; Kenneth D Roth; Travis Nemkov; Angelo D'Alessandro; Joseph T Brozinick; Bryan C Bergman
Journal:  Obesity (Silver Spring)       Date:  2021-03       Impact factor: 5.002

10.  Relative Contribution of Intramyocellular Lipid to Whole-Body Fat Oxidation Is Reduced With Age but Subsarcolemmal Lipid Accumulation and Insulin Resistance Are Only Associated With Overweight Individuals.

Authors:  Carolyn Chee; Chris E Shannon; Aisling Burns; Anna L Selby; Daniel Wilkinson; Kenneth Smith; Paul L Greenhaff; Francis B Stephens
Journal:  Diabetes       Date:  2016-01-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.